Our data show that inhibition of PKC-ι and PKC-ζ significantly decrease the levels of phospho-PTEN and phospho-Akt1 while increasing PTEN levels in both NB cell lines (Figures 3B, D). The gene discussed is AKT1; the disease is neuroblastoma.